CN104086514A - Paclitaxel derivatives and preparation method thereof - Google Patents
Paclitaxel derivatives and preparation method thereof Download PDFInfo
- Publication number
- CN104086514A CN104086514A CN201410276150.5A CN201410276150A CN104086514A CN 104086514 A CN104086514 A CN 104086514A CN 201410276150 A CN201410276150 A CN 201410276150A CN 104086514 A CN104086514 A CN 104086514A
- Authority
- CN
- China
- Prior art keywords
- compound
- solution
- reaction
- ethyl acetate
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 150000004579 taxol derivatives Chemical class 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 12
- 206010006187 Breast cancer Diseases 0.000 claims abstract description 9
- 208000026310 Breast neoplasm Diseases 0.000 claims abstract description 9
- 208000005718 Stomach Neoplasms Diseases 0.000 claims abstract description 9
- 206010017758 gastric cancer Diseases 0.000 claims abstract description 9
- 201000011549 stomach cancer Diseases 0.000 claims abstract description 9
- 201000008808 Fibrosarcoma Diseases 0.000 claims abstract description 8
- 206010025323 Lymphomas Diseases 0.000 claims abstract description 8
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims abstract description 8
- 206010060862 Prostate cancer Diseases 0.000 claims abstract description 8
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims abstract description 8
- 208000032839 leukemia Diseases 0.000 claims abstract description 8
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims abstract description 8
- 201000002528 pancreatic cancer Diseases 0.000 claims abstract description 8
- 208000008443 pancreatic carcinoma Diseases 0.000 claims abstract description 8
- 206010041823 squamous cell carcinoma Diseases 0.000 claims abstract description 8
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims abstract description 7
- 201000007270 liver cancer Diseases 0.000 claims abstract description 7
- 208000014018 liver neoplasm Diseases 0.000 claims abstract description 7
- 201000005202 lung cancer Diseases 0.000 claims abstract description 7
- 208000020816 lung neoplasm Diseases 0.000 claims abstract description 7
- 150000001875 compounds Chemical class 0.000 claims description 406
- 239000000203 mixture Substances 0.000 claims description 57
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims description 18
- 125000005233 alkylalcohol group Chemical group 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 7
- 239000012453 solvate Substances 0.000 claims description 7
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 6
- 201000006491 bone marrow cancer Diseases 0.000 claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 238000011282 treatment Methods 0.000 claims description 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 abstract description 12
- 229960001592 paclitaxel Drugs 0.000 abstract description 12
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract description 12
- 230000001093 anti-cancer Effects 0.000 abstract description 6
- 229940079593 drug Drugs 0.000 abstract description 6
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- 201000000050 myeloid neoplasm Diseases 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 957
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 492
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 486
- 238000006243 chemical reaction Methods 0.000 description 354
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 278
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 207
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 207
- 239000007787 solid Substances 0.000 description 169
- 229910052786 argon Inorganic materials 0.000 description 139
- 238000004440 column chromatography Methods 0.000 description 120
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 116
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 106
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 106
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical class [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 101
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 90
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 74
- 238000005160 1H NMR spectroscopy Methods 0.000 description 53
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 53
- 238000001914 filtration Methods 0.000 description 45
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 42
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 42
- 238000004128 high performance liquid chromatography Methods 0.000 description 38
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 37
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 description 34
- 229940125900 compound 59 Drugs 0.000 description 34
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 32
- 238000001514 detection method Methods 0.000 description 32
- 210000004027 cell Anatomy 0.000 description 25
- 238000005406 washing Methods 0.000 description 24
- 238000001035 drying Methods 0.000 description 23
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000000605 extraction Methods 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 20
- 238000003756 stirring Methods 0.000 description 19
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 14
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 14
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 10
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 10
- LJCZNYWLQZZIOS-UHFFFAOYSA-N 2,2,2-trichlorethoxycarbonyl chloride Chemical compound ClC(=O)OCC(Cl)(Cl)Cl LJCZNYWLQZZIOS-UHFFFAOYSA-N 0.000 description 8
- 239000012300 argon atmosphere Substances 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 description 7
- 206010028980 Neoplasm Diseases 0.000 description 7
- 229940126179 compound 72 Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 description 6
- 238000010791 quenching Methods 0.000 description 6
- 230000000171 quenching effect Effects 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 229940041181 antineoplastic drug Drugs 0.000 description 5
- 229940125904 compound 1 Drugs 0.000 description 5
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 description 4
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 description 4
- 239000002198 insoluble material Substances 0.000 description 4
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 description 3
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 description 3
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 description 3
- UNILWMWFPHPYOR-KXEYIPSPSA-M 1-[6-[2-[3-[3-[3-[2-[2-[3-[[2-[2-[[(2r)-1-[[2-[[(2r)-1-[3-[2-[2-[3-[[2-(2-amino-2-oxoethoxy)acetyl]amino]propoxy]ethoxy]ethoxy]propylamino]-3-hydroxy-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-3-[(2r)-2,3-di(hexadecanoyloxy)propyl]sulfanyl-1-oxopropan-2-yl Chemical compound O=C1C(SCCC(=O)NCCCOCCOCCOCCCNC(=O)COCC(=O)N[C@@H](CSC[C@@H](COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)NCC(=O)N[C@H](CO)C(=O)NCCCOCCOCCOCCCNC(=O)COCC(N)=O)CC(=O)N1CCNC(=O)CCCCCN\1C2=CC=C(S([O-])(=O)=O)C=C2CC/1=C/C=C/C=C/C1=[N+](CC)C2=CC=C(S([O-])(=O)=O)C=C2C1 UNILWMWFPHPYOR-KXEYIPSPSA-M 0.000 description 3
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 description 3
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 description 3
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 description 3
- 0 CCC(C(C)CC1)C1C(C(C)(*)C[C@]1C=*[C@]1C)=C Chemical compound CCC(C(C)CC1)C1C(C(C)(*)C[C@]1C=*[C@]1C)=C 0.000 description 3
- -1 alkane chloride Chemical class 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 229940125782 compound 2 Drugs 0.000 description 3
- 229940126214 compound 3 Drugs 0.000 description 3
- 229940125936 compound 42 Drugs 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 description 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 description 2
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 description 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 description 2
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 description 2
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 description 2
- OMBVEVHRIQULKW-DNQXCXABSA-M (3r,5r)-7-[3-(4-fluorophenyl)-8-oxo-7-phenyl-1-propan-2-yl-5,6-dihydro-4h-pyrrolo[2,3-c]azepin-2-yl]-3,5-dihydroxyheptanoate Chemical compound O=C1C=2N(C(C)C)C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C(C=3C=CC(F)=CC=3)C=2CCCN1C1=CC=CC=C1 OMBVEVHRIQULKW-DNQXCXABSA-M 0.000 description 2
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 description 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 description 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 description 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 description 2
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 description 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 description 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 description 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 description 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 description 2
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 description 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 description 2
- WDBQJSCPCGTAFG-QHCPKHFHSA-N 4,4-difluoro-N-[(1S)-3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-pyridin-3-ylpropyl]cyclohexane-1-carboxamide Chemical compound FC1(CCC(CC1)C(=O)N[C@@H](CCN1CCC(CC1)N1C(=NN=C1C)C(C)C)C=1C=NC=CC=1)F WDBQJSCPCGTAFG-QHCPKHFHSA-N 0.000 description 2
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 2
- 229940126657 Compound 17 Drugs 0.000 description 2
- 229940126639 Compound 33 Drugs 0.000 description 2
- 229940127007 Compound 39 Drugs 0.000 description 2
- LFZAGIJXANFPFN-UHFFFAOYSA-N N-[3-[4-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)piperidin-1-yl]-1-thiophen-2-ylpropyl]acetamide Chemical compound C(C)(C)C1=NN=C(N1C1CCN(CC1)CCC(C=1SC=CC=1)NC(C)=O)C LFZAGIJXANFPFN-UHFFFAOYSA-N 0.000 description 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 description 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 description 2
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 description 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 description 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 description 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 description 2
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 229940125758 compound 15 Drugs 0.000 description 2
- 229940126142 compound 16 Drugs 0.000 description 2
- 229940125810 compound 20 Drugs 0.000 description 2
- 229940126086 compound 21 Drugs 0.000 description 2
- 229940126208 compound 22 Drugs 0.000 description 2
- 229940125833 compound 23 Drugs 0.000 description 2
- 229940125961 compound 24 Drugs 0.000 description 2
- 229940125846 compound 25 Drugs 0.000 description 2
- 229940125851 compound 27 Drugs 0.000 description 2
- 229940125877 compound 31 Drugs 0.000 description 2
- 229940127573 compound 38 Drugs 0.000 description 2
- 229940126540 compound 41 Drugs 0.000 description 2
- 229940125844 compound 46 Drugs 0.000 description 2
- 229940127271 compound 49 Drugs 0.000 description 2
- 229940126545 compound 53 Drugs 0.000 description 2
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 description 2
- JAXFJECJQZDFJS-XHEPKHHKSA-N gtpl8555 Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)N[C@H](B1O[C@@]2(C)[C@H]3C[C@H](C3(C)C)C[C@H]2O1)CCC1=CC=C(F)C=C1 JAXFJECJQZDFJS-XHEPKHHKSA-N 0.000 description 2
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 2
- 125000001165 hydrophobic group Chemical group 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 description 2
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 description 2
- FDBYIYFVSAHJLY-UHFFFAOYSA-N resmetirom Chemical compound N1C(=O)C(C(C)C)=CC(OC=2C(=CC(=CC=2Cl)N2C(NC(=O)C(C#N)=N2)=O)Cl)=N1 FDBYIYFVSAHJLY-UHFFFAOYSA-N 0.000 description 2
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 description 1
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 description 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 description 1
- STBLNCCBQMHSRC-BATDWUPUSA-N (2s)-n-[(3s,4s)-5-acetyl-7-cyano-4-methyl-1-[(2-methylnaphthalen-1-yl)methyl]-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide Chemical compound O=C1[C@@H](NC(=O)[C@H](C)NC)[C@H](C)N(C(C)=O)C2=CC(C#N)=CC=C2N1CC1=C(C)C=CC2=CC=CC=C12 STBLNCCBQMHSRC-BATDWUPUSA-N 0.000 description 1
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 description 1
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 description 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 description 1
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 description 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 description 1
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 1
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 1
- 208000010507 Adenocarcinoma of Lung Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- XJUZRXYOEPSWMB-UHFFFAOYSA-N Chloromethyl methyl ether Chemical compound COCCl XJUZRXYOEPSWMB-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101000573199 Homo sapiens Protein PML Proteins 0.000 description 1
- 206010029350 Neurotoxicity Diseases 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
- 206010044221 Toxic encephalopathy Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 description 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001348 alkyl chlorides Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008499 blood brain barrier function Effects 0.000 description 1
- 210000001218 blood-brain barrier Anatomy 0.000 description 1
- BMQGVNUXMIRLCK-OAGWZNDDSA-N cabazitaxel Chemical compound O([C@H]1[C@@H]2[C@]3(OC(C)=O)CO[C@@H]3C[C@@H]([C@]2(C(=O)[C@H](OC)C2=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=3C=CC=CC=3)C[C@]1(O)C2(C)C)C)OC)C(=O)C1=CC=CC=C1 BMQGVNUXMIRLCK-OAGWZNDDSA-N 0.000 description 1
- 229960001573 cabazitaxel Drugs 0.000 description 1
- 230000007681 cardiovascular toxicity Effects 0.000 description 1
- 231100000060 cardiovascular toxicity Toxicity 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 229940126543 compound 14 Drugs 0.000 description 1
- 229940127204 compound 29 Drugs 0.000 description 1
- 229940125878 compound 36 Drugs 0.000 description 1
- 229940125807 compound 37 Drugs 0.000 description 1
- 229940127113 compound 57 Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 102000054896 human PML Human genes 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 239000003547 immunosorbent Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 201000005249 lung adenocarcinoma Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000007135 neurotoxicity Effects 0.000 description 1
- 231100000228 neurotoxicity Toxicity 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides paclitaxel derivatives with a general structural formula (I) as described in the invention. The invention further provides application of the paclitaxel derivatives in preparation of drugs used for preventing or treating fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostatic cancer, lymphoma, stomach cancer, myeloma and pancreatic cancer. The derivatives synthesized in the invention have better water-solubility compared with paclitaxel and are superior to paclitaxel in the aspect of a plurality of anticancer effects.
Description
Technical Field
The invention belongs to the field of pharmaceutical chemistry, and particularly relates to a taxol derivative and a preparation method thereof.
Background
Paclitaxel is a novel broad-spectrum anti-tumor drug, and has significant curative effect on malignant tumors such as late ovarian cancer, breast cancer, non-small cell lung cancer and the like. And the treatment effect and safety of the traditional Chinese medicine composition are greatly influenced due to poor water solubility, poor selectivity, large toxic and side effects and the like. The new taxol derivative synthesized by the people overcomes the defects to a certain extent and has good biological activity.
Structure of paclitaxel:
malignant tumors are one of the major diseases that currently seriously affect human health and threaten human life. Cancer, together with cardiovascular and cerebrovascular diseases and accidents, constitutes three leading causes of death in all countries of the world today. Therefore, the World Health Organization (WHO) and the government health departments of all countries have cancer as a primary task. The development of new anticancer drugs has been greatly advanced in recent years, the anticancer drug has been paid more and more attention, and paclitaxel has unique anticancer activity and action mechanism, so that paclitaxel becomes a representative of new anticancer drugs of the new generation, and is one of the best anticancer drugs at present. But is not effective for some cancers and is easy to generate multidrug resistance. Paclitaxel has adverse reactions such as anaphylaxis, poor water solubility, neurotoxicity, cardiovascular toxicity and the like. Changing the dosage form and carrying out structural modification on the same become the direction of more researches, and the C of cabazitaxel is overcome7And C10The modification is carried out.
Disclosure of Invention
In view of the above-mentioned drawbacks of the prior art, the present invention provides a paclitaxel derivative and a preparation method thereof, and the paclitaxel derivative and the preparation method thereof are intended to solve the technical problems of limited effect and great side effect of paclitaxel in the prior art for treating cancer.
The invention provides a compound represented by a general formula (I), wherein the structural formula of the compound is as follows:
wherein: r1The radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R2the radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
Further, wherein,
R1the radical being C1-6Alkyl, or C3-8A cycloalkyl group;
R2the radical being C1-6Alkyl radical, C3-16Cycloalkyl, - (C ═ O) - (C)1-8Alkyl), or-CH2-O-(C1-6Alkyl groups);
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
Further, in the above-mentioned case,
wherein,
R1the radical is- (C ═ O) - (C)1-8Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R2the radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-8Alkyl), or-CH2-O-(C1-6Alkyl groups);
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
Further, the structural formula is
The invention also provides an isomer, a racemate, a pharmaceutically acceptable salt, a crystalline hydrate, a solvate or a mixture thereof of the compound.
The invention also provides a pharmaceutical composition, which comprises an effective amount of isomers, racemes, pharmaceutically acceptable salts, crystal hydrates, solvates or mixtures thereof of the compounds, and one or more pharmaceutically acceptable carriers.
The invention also provides application of the pharmaceutical composition in preparing medicines for preventing or treating fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostatic cancer, lymphoma, gastric cancer, bone marrow cancer and pancreatic cancer.
The invention also provides application of the compound in preparing medicaments for preventing or treating fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostatic cancer, lymphoma, gastric cancer, bone marrow cancer and pancreatic cancer.
The invention also provides an application of the isomer, the racemate, the pharmaceutically acceptable salt, the crystal hydrate, the solvate or the mixture of the isomer, the racemate, the pharmaceutically acceptable salt, the crystal hydrate and the solvate of the compound in preparing medicaments for preventing or treating fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostatic cancer, lymphoma, gastric cancer, bone marrow cancer and pancreatic cancer.
The hydrophobic group in the compound has better anticancer activity and can help to pass through the blood brain barrier. Meanwhile, the compound synthesized by the invention has better water solubility than paclitaxel and better anticancer effect than paclitaxel.
Detailed Description
EXAMPLE 1 Synthesis of Compound 56
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of compound 55(3g, 5.51mmol) under argon atmosphere at 0 ℃ to react at room temperature for 1 hour, TLC checked for completion of the reaction, pyridine was removed under reduced pressure, 80ml ethyl acetate and 50ml water were added, extraction was performed with ethyl acetate (50ml × 2), washing was performed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave compound 56(3.96g, 81%) as a white solid.
EXAMPLE 2 Synthesis of Compound 58
Compound 56(3g, 3.36mmol), compound 57(3.24g), DCC, DMAP were sequentially added to a reaction flask, 68mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 2 hours and then HPLC monitored for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, stirring was carried out for 20min, insoluble matter was removed by filtration, extraction was carried out with ethyl acetate (50mL × 2), washing was carried out with saturated sodium chloride (50mL), drying was carried out with anhydrous sodium sulfate, concentration was carried out, and column chromatography was carried out (PE: EA ═ 3: 1) to obtain compound 58(3.70g, 92%).
EXAMPLE 3 Synthesis of Compound 59
To a solution of compound 58(3.7g, 3.09mmol) in methanol (120ml) were added zinc powder (6.75g, 92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours and then the reaction was checked by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound 59(2.53g, 90%) as a white solid.
EXAMPLE 4 Synthesis of Compound 60
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1h, MeI (3ml) is added, after 12h reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, after 4h reaction at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeI are removed under reduced pressure, 20ml of ethyl acetate and 5ml of water are added, extraction is carried out with ethyl acetate (10 ml. times.2), washing is carried out with saturated sodium chloride solution (5ml), drying is carried out with anhydrous sodium sulfate, concentration is carried out, and column chromatography (PE: EA is 2: 1) is carried out to obtain 60(56.1ml, 54%) of a white solid compound.
EXAMPLE 5 Synthesis of Compound 61
To a solution of compound 60(50mg, 0.052mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (11mg, 0.058mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 61 as a white solid (27.2mg, 62%).1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
Synthetic route to compound 61:
EXAMPLE 6 Synthesis of Compound 63
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound 62 in toluene and DCE (1: 1) (5ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml), the temperature was raised to 50 ℃, the reaction was 12h, TLC detected complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound 63(31.0ml, 23%) as a white solid.
EXAMPLE 7 Synthesis of Compound 64
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of compound 63(100mg, 0.082mmol) at 0 ℃ for 8h, TLC detected complete reaction, quenched with saturated ammonium chloride solution (1ml), methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 64(40.4mg, 50%) as a white solid.
EXAMPLE 8 Synthesis of Compound 1
To a solution of compound 64(40.4mg, 0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 1 as a white solid (23.6mg, 65%).1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
Synthetic route to Compound 1
EXAMPLE 9 Synthesis of Compound 65
Compound 59(100mg, 0.11mmol) in DCM (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), MOMCl (0.041ml, 0.54mmol) under argon at 0 ℃, warmed to room temperature for 12h, TLC detected for reaction completion, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 5ml ethyl acetate, 5ml water, extracted with ethyl acetate (5ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound 65(89.9mg, 72%) as a white solid.
EXAMPLE 10 Synthesis of Compound 2
To a solution of compound 65(89.9mg, 0.090mmol) in methanol (3ml) was added p-toluenesulfonic acid (17.0mg, 0.099mmol), stirred at room temperature for 1h, TLC detected for reaction completion, saturated sodium bicarbonate (2ml), quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 2(23.6mg, 65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,5H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
Synthesis of Compound 2
EXAMPLE 11 Synthesis of Compound 67
Compound 59(100mg, 0.11mmol), compound 66(47.8mg, 0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extraction was performed with ethyl acetate (5mL × 2), washing was performed with a saturated sodium chloride solution (5mL), drying was performed with anhydrous sodium sulfate, concentration was performed, and column chromatography (PE: EA ═ 3: 1) gave compound 67(110.72mg, 63%).
EXAMPLE 12 Synthesis of Compound 68
Under the protection of argon, a THF solution of TBAF (69.2mg, 0.265mmol) was added dropwise to a THF (2ml) solution of compound 67(100mg, 0.063mmol) at 0 ℃ for 8h, TLC detected complete reaction, quenched with saturated ammonium chloride (1ml), methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 68(41.7mg, 58%) as a white solid.
EXAMPLE 13 Synthesis of Compound 3
To a solution of compound 68(41.7mg, 0.037mmol) in methanol (2ml) was added p-toluenesulfonic acid (7.0mg, 0.041mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 3 as a white solid (26.9mg, 71%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
Synthesis of Compound 3
Example 14 Synthesis of Compound 70 and Synthesis of Compound 63.
Example 15 Synthesis of Compound 4 Synthesis of Compound 1, Compound 2 and Compound 3.
Synthesis of Compound 4
Example 16 Synthesis of Compound 72 was followed by Synthesis of Compound 63.
Example 17 Synthesis of Compound 5 Synthesis of Compound 1, Compound 2 and Compound 3.
Synthesis of Compound 5
Example 18
Compound 6
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml), the temperature was raised to 50 ℃, the reaction was 12h, TLC detected complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound 72(28.2mg, 24%) as a white solid.
EXAMPLE 19 Synthesis of Compound 73
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of compound 72(100mg, 0.094mmol) at 0 ℃ for 8h, TLC detected complete reaction, quenched with saturated ammonium chloride solution (1ml), methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give 51% yield of the compound as a white solid.
To a solution of the above compound (40.4mg, 0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 6(23.7mg, 65.3%) as a white solid. Compound 6:1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.28(s,3H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 20 Compound 7
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml), the temperature was raised to 50 ℃, the reaction was 12h, TLC detected complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml ethyl acetate, 5ml water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound 63 as a white solid (31.0ml, 23%).
Compound 59(100mg, 0.11mmol), compound 66(47.8mg, 0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extraction was performed with ethyl acetate (5mL × 2), washing was performed with a saturated sodium chloride solution (5mL), drying was performed with anhydrous sodium sulfate, concentration was performed, and column chromatography (PE: EA ═ 3: 1) gave compound 67(110.72mg, 63%).
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of compound 75(0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave compound 76 (50.3%) as a white solid.
To a solution of compound 76(40.4mg, 0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 7 (66%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.81-3.76(m,5H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 21 Compound 8
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml), the temperature was raised to 50 ℃, the reaction was 12h, TLC detected complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound 72 (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound b in toluene and DCE (1: 1) (5ml) solution were slowly added dropwise to compound 72(0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, TLC detection reaction was complete, cooling, quenching with saturated ammonium chloride (3ml), concentration, addition of 20ml ethyl acetate, 5ml water, extraction with ethyl acetate (10ml × 2), washing with saturated sodium chloride (5ml), drying over anhydrous sodium sulfate, concentration, column chromatography (PE: EA ═ 2: 1) gave compound 77 (23%) as a white solid.
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of compound 77(0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave compound 78 (50.3%) as a white solid.
To a solution of compound 78(0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 8 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H)1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 22 Compound 9
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml), the temperature was raised to 50 ℃, the reaction was 12h, TLC detected complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound 72 (23%) as a white solid.
Under the protection of argon, compound 72(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound b in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound 79 (23%) as a white solid.
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave compound 80 (50.3%) as a white solid.
To a solution of compound 80(0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 9 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H)1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 23 Compound 10
Under the protection of argon, compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
The above compound (100mg, 0.11mmol), compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble materials were removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound (61%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 10 (62%) as a white solid.
1H NMR(400MHz,CDCl3)::δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.43-5.47(m,2H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 24 Compound 11
Under the protection of argon, compound 59(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), compound b in toluene and DCE (1: 1) (5ml) was slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the reaction was checked by TLC to be complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml of ethyl acetate and 5ml of water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound 79 (23%) as a white solid.
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of the above compound (0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave a white solid compound (50.7%).
To a solution of compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 11 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.43-5.47(m,2H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,4H),3.45(s,1H),3.30(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 25 Compound 12
Under the protection of argon, compound 59(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml ethyl acetate, 5ml water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (23%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC checked for completion of the reaction, and quenched with saturated sodium bicarbonate solution (2ml)Then, methanol was removed under reduced pressure, and the extract was extracted with ethyl acetate (10 ml. times.3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 3: 1) to give compound 12 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,2H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.32(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H),1.10(s,3H)ppm.
EXAMPLE 26 Compound 13
Under the protection of argon, compound 59(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
The above compound (0.11mmol), compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound (63.3%).
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of the above compound (0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave a white solid compound (50.3%).
To a solution of compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 13 as a white solid (61.3%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 27 Compound 14
Under the protection of argon, compound 59(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
The above compound (0.11mmol), compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound (63.3%).
Under the protection of argon, a THF solution of TBAF (38.9mg, 0.180mmol) was added dropwise to a THF (2ml) solution of the above compound (0.082mmol) at 0 ℃ for 8h, the reaction was complete by TLC detection, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 3: 1) gave a white solid compound (51.3%).
To a solution of compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected complete reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 13 as a white solid (61.4%).1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.81-3.76(m,4H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H)1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 28 Compound 15
Under the protection of argon, compound 59(0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml ethyl acetate, 5ml water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (23%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 15 (63%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,4H),3.80(d,J=7.5Hz,1H),3.55-3,72(m,4H),3.47-3.52(m,2H),3.45(s,1H),3.32(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H),1.10(s,3H),ppm.
EXAMPLE 29 Compound 16
Compound 59(100mg, 0.11mmol), compound 66(47.8mg, 0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound (61.3%).
The above compound (0.11mmol), compound 66(47.8mg, 0.132mmol), DCC, and DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours, then HPLC was used to monitor completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound (63%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give the compound as a white solid (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 16 (63%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 30 Compound 17
Compound 59(0.11mmol), compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (63.7%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 17 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,4H),3.55-3.72(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,6H),2.36(s,6H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 31 Compound 18
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the reaction was detected by TLC completely, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml of ethyl acetate and 5ml of water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave the compound as a white solid (23.2%).
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the reaction was detected by TLC completely, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml of ethyl acetate, 5ml of water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23.7%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 18 (63%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,4H),3.62(s,2H)3.45(s,1H),3.32(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 32 Compound 19
Under the protection of argon, compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to give compound (23%) as a white solid.
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (63%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give the compound as a white solid (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 19 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,4H),3.45(s,1H),3.30(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 33 Compound 20
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the reaction was detected by TLC completely, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml of ethyl acetate, 5ml of water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (24.2%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the above compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (51.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 20 (63%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,8H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 34 Compound 21
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the reaction was detected by TLC completely, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml of ethyl acetate, 5ml of water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23.1%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (50.6%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 21 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,10H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H),1.10(s,3H)ppm.
EXAMPLE 35 Compound 22
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (63%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give the compound as a white solid (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 22 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,2H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.32(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 36 Compound 23
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml ethyl acetate, 5ml water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (22.3%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 23 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,2H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 37 Compound 24
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, the reaction was cooled, quenched with saturated ammonium chloride (3ml), concentrated, 20ml ethyl acetate, 5ml water were added, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (23%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 24 (63%) as a white solid.1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,2H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,6H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 38 Compound 25
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene of compound (0.11mmol) and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (23%) as a white solid.
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (63%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give the compound as a white solid (50.3%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 25 (63%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.84-3.76(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 39 Compound 26
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.84-3.76(m,10H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
Under the protection of argon, compound 59(100mg, 0.11mmol) in toluene and DCE (1: 1) (5ml) was slowly added dropwise DIPEA (0.5ml, 0.54mmol), compound a in toluene and DCE (1: 1) (5ml) at 0 ℃, heated to 50 ℃, reacted for 12h, TLC detected reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain compound (21-26%) as a white solid.
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 26 (61-67%) as a white solid.
EXAMPLE 40 Compound 27
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (21-25%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extraction was performed with ethyl acetate (5ml × 3), washing was performed with a saturated sodium chloride solution (5ml), drying was performed with anhydrous sodium sulfate, concentration was performed, and column chromatography (PE: EA ═ 3: 1) gave a white solid compound (49.9-54.6%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 27 (61-65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.84-3.76(m,10H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 41 Compound 28
The compound (0.11mmol), the compound (0.132mmol), DCC, and dm.ap were sequentially added to a reaction flask, 5mL of toluene was added under the protection of argon, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the reaction was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 28 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.84-3.76(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,6H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 42 Compound 29
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the reaction was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 28 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,2H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.84-3.76(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,6H),2.24-2.29(m,4H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,3H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 43 Compound 30
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the reaction was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 30 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.28(s,3H),2.24-2.29(m,6H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 44 Compound 31
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the reaction was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 31 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,2H),3.80(d,J=7.5Hz,1H),3.45(s,3H),2.36(s,3H),2.24-2.29(m,4H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 45 Compound 32
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the reaction was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 32 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,4H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 46 Compound 33
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 33 (61-67%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,6H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 47 Compound 34
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (49.9-54.6%).
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1h, chloroalkane (3ml) is added, after 12h reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, reaction is further carried out for 4h at 0 ℃, the temperature is lowered to-78 ℃, quenching is carried out with a saturated ammonium chloride solution (3ml), DMF and MeI are removed under reduced pressure, 20ml of ethyl acetate and 5ml of water are added, extraction is carried out with ethyl acetate (10 ml. times.2), washing is carried out with a saturated sodium chloride solution (5ml), drying is carried out with anhydrous sodium sulfate, concentration is carried out, and column chromatography (PE: EA is 2: 1) is carried out to obtain a white solid compound 60(56.1ml, 54%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 34 (61-65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,4H),3.80(d,J=7.5Hz,1H),3.55-3.72(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 48 Compound 35
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the compound (3.09mmol) in methanol (120ml) were added zinc powder (92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours and then the reaction was checked by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (90%).
Adding p-toluenesulfonic acid (0.058mmol) into a methanol (1.3ml) solution of the compound (0.052mmol), stirring at room temperature for 1h, detecting by TLC that the reaction is complete, quenching with a saturated sodium bicarbonate solution (2ml), removing methanol under reduced pressure, extracting with ethyl acetate (10 ml. times.3), washing with a saturated sodium chloride solution (5ml), drying over anhydrous sodium sulfate, concentrating, and performing column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,3H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,6H),1.79-1.82(m,3H),1.76(s,3H),1.59-1.71(m,4H),1.27(s,3H),1.25(s,3H),1.10(s,3H)ppm.
EXAMPLE 49 Compound 36
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the compound (3.09mmol) in methanol (120ml) were added zinc powder (92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours and then the reaction was checked by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (90%).
Adding p-toluenesulfonic acid (0.058mmol) into a methanol (1.3ml) solution of the compound (0.052mmol), stirring at room temperature for 1h, detecting by TLC that the reaction is complete, quenching with a saturated sodium bicarbonate solution (2ml), removing methanol under reduced pressure, extracting with ethyl acetate (10 ml. times.3), washing with a saturated sodium chloride solution (5ml), drying over anhydrous sodium sulfate, concentrating, and performing column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,6H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 50 Compound 37
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the compound (3.09mmol) in methanol (120ml) were added zinc powder (92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours and then the reaction was checked by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (90%).
Adding p-toluenesulfonic acid (0.058mmol) into a methanol (1.3ml) solution of the compound (0.052mmol), stirring at room temperature for 1h, detecting by TLC that the reaction is complete, quenching with a saturated sodium bicarbonate solution (2ml), removing methanol under reduced pressure, extracting with ethyl acetate (10 ml. times.3), washing with a saturated sodium chloride solution (5ml), drying over anhydrous sodium sulfate, concentrating, and performing column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,12H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 51 Compound 38
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give a white solid compound (49.9-54.6%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 38 (61-65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 52 Compound 39
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 39 (61-65%) as a white solid.
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of the compound (0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (49.9-54.6%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 53 Compound 40
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1h, alkane chloride (3ml) is added, after 12h reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, after 4h reaction at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeCl are removed under reduced pressure, 20ml ethyl acetate and 5ml water are added, extraction is carried out with ethyl acetate (10ml multiplied by 2), washing is carried out with saturated sodium chloride solution (5ml), drying is carried out with anhydrous sodium sulfate, concentration is carried out, and column chromatography (PE: EA equals to 2: 1) is carried out to obtain a white solid compound 40 (54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,5H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 54 Compound 41
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1h, alkane chloride (3ml) is added, after 12h reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, after 4h reaction at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeCl are removed under reduced pressure, 20ml ethyl acetate and 5ml water are added, extraction is carried out with ethyl acetate (10ml multiplied by 2), washing is carried out with saturated sodium chloride solution (5ml), drying is carried out with anhydrous sodium sulfate, concentration is carried out, and column chromatography (PE: EA equals to 2: 1) is carried out to obtain white solid compound 42 (54%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 41 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.36(s,6H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 55 Compound 42
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1h, alkane chloride (3ml) is added, after 12h reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, after 4h reaction at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeCl are removed under reduced pressure, 20ml ethyl acetate and 5ml water are added, extraction is carried out with ethyl acetate (10ml multiplied by 2), washing is carried out with saturated sodium chloride solution (5ml), drying is carried out with anhydrous sodium sulfate, concentration is carried out, and column chromatography (PE: EA is 2: 1) is carried out to obtain white solid compound 42 (54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 56 Compound 43
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound 43 (49-54%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.81-3.76(m,5H3.47-3.52(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H),1.10(s,6H)ppm.
EXAMPLE 57 Compound 44
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,3H),5.43-5.47(m,5H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.80(d,J=7.5Hz,1H),3.45(s,1H),3.30(s,3H),2.36(s,3H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 58 Compound 45
The compound (0.11mmol), the compound (0.132mmol), DCC, DMAP were sequentially added to a reaction flask, 5mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 5 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 5mL of ethyl acetate and 5mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (5mL × 2), washed with a saturated sodium chloride solution (5mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (60-64%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound (49-54%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,3H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,8H),3.80(d,J=7.5Hz,1H),3.45(s,1H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.36(s,6H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 59 Compound 46
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 46 (61-65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,3H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,2H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 60 Compound 47
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 47 (61-65%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,3H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.55-3.72(m,4H),3.47-3.52(m,4H),3.45(s,1H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 61 Compound 48
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (3.36mmol), the compound, DCC, and DMAP were sequentially added to a reaction flask, 68mL of toluene was added under the protection of argon, the reaction was stirred at 85 ℃ for 2 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (50mL × 2), washed with saturated sodium chloride (50mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (92%).
To a solution of the compound (3.09mmol) in methanol (120ml) were added zinc powder (92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours, followed by detection of completion of the reaction by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (87-93%).
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), MeI (3ml) is added after stirring for 1h, after 12h of reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, the reaction is further carried out for 4h at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeI are removed under reduced pressure, 20ml of ethyl acetate and 5ml of water are added, the mixture is extracted with ethyl acetate (10 ml. times.2), the mixture is washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate and concentrated, and the white solid compound 60(56.1ml, 54%) is obtained by column chromatography (PE: EA is 2: 1).
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extraction was performed with ethyl acetate (5ml × 3), washing was performed with a saturated sodium chloride solution (5ml), drying was performed with anhydrous sodium sulfate, concentration was performed, and column chromatography (PE: EA ═ 3: 1) gave compound 48 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,9H),3.45(s,1H),2.36(s,3H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 62 Compound 49
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (3.36mmol), the compound, DCC, and DMAP were sequentially added to a reaction flask, 68mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 2 hours, followed by HPLC monitoring for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, the mixture was stirred for 20min, insoluble materials were removed by filtration, extracted with ethyl acetate (50mL × 2), washed with saturated sodium chloride (50mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (92%).
Under the protection of argon, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) is slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), MeI (3ml) is added after stirring for 1h, after 12h of reaction, the temperature is naturally raised to 0 ℃, the temperature is raised to 5h, the reaction is further carried out for 4h at 0 ℃, the temperature is lowered to-78 ℃, the solution is quenched with saturated ammonium chloride solution (3ml), DMF and MeI are removed under reduced pressure, 20ml of ethyl acetate and 5ml of water are added, the mixture is extracted with ethyl acetate (10 ml. times.2), the mixture is washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate and concentrated, and the white solid compound 60(56.1ml, 54%) is obtained by column chromatography (PE: EA is 2: 1).
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give compound 49 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,9H),3.45(s,1H),2.36(s,3H),2.24-2.29(m,3H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,8H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 63 Compound 50
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (3.36mmol), the compound, DCC, and DMAP were sequentially added to a reaction flask, 68mL of toluene was added under the protection of argon, the reaction was stirred at 85 ℃ for 2 hours and then monitored by HPLC for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, the mixture was stirred for 20min, insoluble matter was removed by filtration, extracted with ethyl acetate (50mL × 2), washed with saturated sodium chloride (50mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (92%).
To a solution of the compound (3.09mmol) in methanol (120ml) were added zinc powder (92.87mmol) and acetic acid in this order, reacted at 30 ℃ for 5 hours and then the reaction was checked by TLC, the zinc powder was removed by filtration, the methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (90%).
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-67%).
Under argon protection, a solution of LiHMDS (0.5ml, 0.54mmol) in DMF (10ml) was slowly added dropwise to a solution of compound 59(100mg, 0.11mmol) in DMF (10ml), after stirring for 1 hour, MeCl (3ml) was added, after 12 hours of reaction, the temperature was naturally raised to 0 ℃ and the temperature was raised to 5 hours, and the reaction was further carried out at 0 ℃ for 4 hours, and the temperature was lowered to-78 ℃, and the mixture was quenched with a saturated ammonium chloride solution (3ml), DMF and MeI were removed under reduced pressure, 20ml of ethyl acetate and 5ml of water were added, and the mixture was extracted with ethyl acetate (10 ml. times.2), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA: 2: 1) to obtain a white solid compound 60(56.1ml, 54%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound 50 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,9H),3.55-3.72(m,9H),3.45(s,1H),2.36(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 64 Compound 51
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound b and DCE (1: 1) (5ml) solution were slowly added dropwise to the above compound (0.11mmol) in toluene and DCE (1: 1) (5ml) solution at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatography (PE: EA ═ 2: 1) gave compound (21-25%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC detected for completion of the reaction, saturated sodium bicarbonate solution (2ml) quenched, methanol removed under reduced pressure, extracted with ethyl acetate (10ml × 3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 3: 1) to give the compound as a white solid (61-65%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, the reaction was completed, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extraction was performed with ethyl acetate (5ml × 3), washing was performed with a saturated sodium chloride solution (5ml), drying was performed with anhydrous sodium sulfate, concentration was performed, and column chromatography (PE: EA ═ 3: 1) gave compound 51 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43-5.47(m,5H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,5H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 65 Compound 52
TrocCl (2.49ml, 18.18mmol) was added dropwise to a pyridine (54ml) solution of the compound (5.51mmol) at 0 ℃ under an argon atmosphere, the reaction was carried out at room temperature for 1 hour, the completion of the reaction was detected by TLC, pyridine was removed under reduced pressure, 80ml of ethyl acetate and 50ml of water were added, extraction was carried out with ethyl acetate (50ml × 2), washing was carried out with saturated sodium chloride (50ml), drying was carried out over anhydrous sodium sulfate, concentration was carried out, and column chromatography (PE: EA ═ 3: 1) was carried out to obtain a white solid compound (79-83%).
The compound (3.36mmol), the compound, DCC, and DMAP were sequentially added to a reaction flask, 68mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 2 hours, followed by HPLC monitoring for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, the mixture was stirred for 20min, insoluble materials were removed by filtration, extracted with ethyl acetate (50mL × 2), washed with saturated sodium chloride (50mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (87-93%).
After zinc powder (92.87mmol) and acetic acid were added to a solution of compound (3.09mmol) in methanol (120ml) in this order, and reacted at 30 ℃ for 5 hours, the reaction was checked by TLC, the zinc powder was removed by filtration, methanol and acetic acid were removed under reduced pressure, 100ml of ethyl acetate and 50ml of water were added, extracted with ethyl acetate (50ml × 2), washed with saturated sodium chloride (50ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound (89-91%).
The compound (3.36mmol), the compound, DCC, and DMAP were sequentially added to a reaction flask, 68mL of toluene was added under argon protection, the reaction was stirred at 85 ℃ for 2 hours, followed by HPLC monitoring for completion of the reaction, toluene was removed under reduced pressure, 80mL of ethyl acetate and 50mL of water were added, the mixture was stirred for 20min, insoluble materials were removed by filtration, extracted with ethyl acetate (50mL × 2), washed with saturated sodium chloride (50mL), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain the compound (87-93%).
Adding p-toluenesulfonic acid (11mg, 0.058mmol) to a solution of compound (0.052mmol) in methanol (1.3ml), stirring at room temperature for 1h, detecting by TLC that the reaction was complete, quenching with saturated sodium bicarbonate solution (2ml), removing methanol under reduced pressure, extracting with ethyl acetate (10 ml. times.3), washing with saturated sodium chloride solution (5ml), drying over anhydrous sodium sulfate, concentrating, and performing column chromatography (PE: EA ═ 3: 1) to obtain a white solid compound
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC, and a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to obtain compound 52 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3)∶δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.82-3.84(m,8H),3.81-3.76(m,5H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,6H),1.27(s, 3H),1.25(s,3H)ppm.
EXAMPLE 66 Compound 53
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC checked for completion of the reaction, and saturated sodium bicarbonate solution (2ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (10 ml. times.3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, and concentrated to give the compound as a white solid (61-65%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound 53 as a white solid (49.9-54.6%).
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,9H),3.55-3.72(m,4H),3.45(s,1H),3.32(s,3H),3.28(s,3H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.27(s,3H),1.25(s,3H)ppm.
EXAMPLE 67 Compound 54
Under the protection of argon, DIPEA (0.5ml, 0.54mmol), toluene of compound a and DCE (1: 1) (5ml) solution were slowly added dropwise to the toluene and DCE (1: 1) (5ml) solution of compound (0.11mmol) at 0 ℃, the temperature was raised to 50 ℃, the reaction was 12h, the TLC detection reaction was complete, cooled, quenched with saturated ammonium chloride (3ml), concentrated, added with 20ml ethyl acetate, 5ml water, extracted with ethyl acetate (10ml × 2), washed with saturated sodium chloride (5ml), dried over anhydrous sodium sulfate, concentrated, and column chromatographed (PE: EA ═ 2: 1) to obtain the compound (21-24%) as a white solid.
To a solution of the above compound (0.041mmol) in methanol (1.3ml) was added p-toluenesulfonic acid (7.7mg, 0.045mmol), stirred at room temperature for 1h, TLC checked for completion of the reaction, and saturated sodium bicarbonate solution (2ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (10 ml. times.3), washed with saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, and concentrated to give the compound as a white solid (61-65%).
Under the protection of argon, a THF solution of TBAF (0.180mmol) was added dropwise to a THF (2ml) solution of compound 79(0.082mmol) at 0 ℃ for 8h, the reaction was checked by TLC for completion, a saturated ammonium chloride solution (1ml) was quenched, methanol was removed under reduced pressure, extracted with ethyl acetate (5ml × 3), washed with a saturated sodium chloride solution (5ml), dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (PE: EA ═ 3: 1) to give compound 54 (49.9-54.6%) as a white solid.
1H NMR(400MHz,CDCl3):δ8.08(d,J=7.5Hz,2H),7.60(t,J=7.5Hz,1H),7.48(t,J=7.5Hz,2H),7.39-7.40(m,4H),7.34-7.31(m,1H),6.20(t,J=9Hz,1H),5.62(d,J=7.5Hz,1H),5.43(d,J=10.0Hz,1H),5.27(s,1H),4.96(d,J=10Hz,1H),4.80(s,1H),4.62(s,1H),4.29(d,J=8.5Hz,1H),4.17(d,J=8.5Hz,1H),3.85(dd,J=11.0Hz,J=6.5Hz,1H),3.81-3.76(m,9H),3.55-3.72(m,4H),3.47-3.52(m,4H),3.45(s,1H),2.24-2.29(m,2H),2.04(s,3H),1.87(s,3H),1.79-1.82(m,1H),1.76(s,3H),1.59-1.71(m,4H),1.36(s,9H),1.27(s,3H),1.25(s,3H),1.10(s,6H)ppm.
EXAMPLE 68 test for the Activity of Compounds on cancer cells
1. The experimental principle is as follows: inhibition of cancer cell growth by compounds was measured by the MTT method. The principle of MTT method is that yellow thiazole blue can penetrate cell membrane to enter into cell, succinate dehydrogenase in mitochondria of living cell can reduce exogenous MTT to water-insoluble blue-purple crystalline Formazan (Formazan) and deposit in cell, while dead cell has no function. Dimethyl sulfoxide (DMSO) can dissolve formazan in cells, and its light absorption value is measured at 570nm wavelength by enzyme linked immunosorbent detector, which can indirectly reflect living cell number.
2. Experimental materials: the cell lines used were HT1080 (human fibrosarcoma cell), Huh-7 (human hepatoma cell line), A549 (human lung adenocarcinoma cell line), Hela (human cervical cancer cell), HL60 (human promyelocytic leukemia cell line), A431 (epidermoid carcinoma cell line), MCF-7 (human breast cancer), DU145 (human prostate cancer cell), U937 (lymphoma cell line of human tissue cells), BEL-7402 (hepatocellular carcinoma), SGC-7901 (human gastric cancer cell line), K562 (human leukemia cell line), PANC-1 (human pancreatic cancer cell line), BGC823 (human gastric cancer cell line), Molt-4 (human acute lymphoblastic leukemia cell line); culture was performed with DMEM + 10% FBS medium or 1640+ 10% FBS medium, respectively.
3. Experimental methods and analysis of results:
experimental groups: 190 μ l of cell suspension +10 μ l of different concentrations of drug (final concentration 10-5 ~ 10-10M)
Blank control group: 200 μ l PBS
Negative control group: 190. mu.l of cell suspension + 10. mu.l of 2% DMSO (final DMSO concentration: 0.1%)
Positive control group: 190. mu.l cell suspension + 10. mu.l of different concentrations of the compound
a) Inoculating the cells into a 96-well plate, wherein the inoculation amount is 1500/well and 190 mu l/well, and culturing overnight in a 37 ℃ 5% CO2 incubator;
b) adding 10 mul of different drugs into each hole every day, wherein the final concentration of the drugs is 10 < -5 > to 10 < -10 > M, and three parallel holes are formed; incubating in a 5% CO2 incubator at 37 ℃ for 72 hours;
c) add 20. mu.l of 5mg/ml MTT per well and incubate for 4 hours at 37 ℃ in 5% CO2 incubator;
d) discarding the supernatant, adding 100 μ l DMSO into each well, and oscillating;
e) 570nm readings, cell viability was calculated and GI50 was calculated from the results, as shown in the table below.
TABLE 1
TABLE 2
TABLE 3
TABLE 4
TABLE 5
TABLE 6
TABLE 7
TABLE 8
TABLE 9
GI50 in the above table represents the drug concentration required for 50% growth inhibition of cells.
From the results in the table above, it can be seen that: the effect of the compounds on inhibiting certain cancer cells is equivalent to or more remarkable than that of paclitaxel.
In conclusion, the synthesized taxol derivative has better water solubility than taxol and better anticancer effect. And hydrophobic groups have better anticancer activity.
The above description is only a basic description of the present invention, and any equivalent changes made according to the technical solution of the present invention should fall within the protection scope of the present invention.
Claims (9)
1. A compound represented by the general formula (I) having the following structural formula:
wherein: r1The radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R2the radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
2. The compound represented by the general formula (I) according to claim 1, characterized in that:
wherein,
R1the radical being C1-6Alkyl, or C3-8A cycloalkyl group;
R2the radical being C1-6Alkyl radical, C3-16Cycloalkyl, - (C ═ O) - (C)1-8Alkyl), or-CH2-O-(C1-6Alkyl groups);
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
3. The compound represented by the general formula (I) according to claim 1, characterized in that:
wherein,
R1the radical is- (C ═ O) - (C)1-8Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R2the radical being C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-8Alkyl), or-CH2-O-(C1-6Alkyl groups);
R3group H, C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol;
R4the radical is(C1-6Alkyl group), C1-6Alkyl radical, C3-8Cycloalkyl, - (C ═ O) - (C)1-6Alkyl), -CH2-O-(C1-6Alkyl), or C1-6An alkyl alcohol.
4. The compound represented by the general formula (I) according to claim 1, characterized in that: the structural formula is
5. An isomer, racemate, pharmaceutically acceptable salt, crystalline hydrate, solvate or mixture thereof of the compound according to claim 1 to 4.
6. A pharmaceutical composition comprising an effective amount of an isomer, racemate, pharmaceutically acceptable salt, crystalline hydrate, solvate or mixture thereof, selected from the compounds according to any one of claims 1 to 4, and one or more pharmaceutically acceptable carriers.
7. Use of a pharmaceutical composition according to claim 6 for the preparation of a medicament for the prevention or treatment of fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostate cancer, lymphoma, stomach cancer, bone marrow cancer and pancreatic cancer.
8. Use of a compound according to any one of claims 1 to 4 for the manufacture of a medicament for the prophylaxis or treatment of fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostate cancer, lymphoma, stomach cancer, bone marrow cancer and pancreatic cancer.
9. Use of an isomer, racemate, pharmaceutically acceptable salt, crystalline hydrate, solvate or mixture thereof of the compound according to any one of claims 1 to 4 for the preparation of a medicament for the prophylaxis or treatment of fibrosarcoma, liver cancer, lung cancer, leukemia, epidermoid carcinoma, breast cancer, prostate cancer, lymphoma, stomach cancer, bone marrow cancer and pancreatic cancer.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410276150.5A CN104086514A (en) | 2014-06-19 | 2014-06-19 | Paclitaxel derivatives and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410276150.5A CN104086514A (en) | 2014-06-19 | 2014-06-19 | Paclitaxel derivatives and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104086514A true CN104086514A (en) | 2014-10-08 |
Family
ID=51634304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410276150.5A Pending CN104086514A (en) | 2014-06-19 | 2014-06-19 | Paclitaxel derivatives and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104086514A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107141272A (en) * | 2017-06-30 | 2017-09-08 | 重庆市碚圣医药科技股份有限公司 | A kind of semi-synthetic docetaxel method and its intermediate |
WO2020177748A1 (en) * | 2019-03-05 | 2020-09-10 | 中国医学科学院药物研究所 | Quaternized modified taxane derivative, and pharmaceutical composition and use thereof |
CN113698369A (en) * | 2021-08-31 | 2021-11-26 | 无锡紫杉药业有限公司 | Method for removing specific single impurity in cabazitaxel |
CN113698368A (en) * | 2021-08-27 | 2021-11-26 | 无锡紫杉药业有限公司 | Preparation method of cabazitaxel |
CN115232092A (en) * | 2022-05-19 | 2022-10-25 | 无锡紫杉药业有限公司 | Preparation method of 10-acetyl docetaxel |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0694539A1 (en) * | 1994-07-28 | 1996-01-31 | Bristol-Myers Squibb Company | 7-o-Ethers of taxane derivatives |
CN1151740A (en) * | 1994-06-28 | 1997-06-11 | 法玛西雅厄普约翰美国公司 | 7-ether-taxol analogs, antineoplastic use and pharmaceutical compsns. containing them |
CN1179775A (en) * | 1995-03-27 | 1998-04-22 | 罗纳-布朗克罗莱尔股份有限公司 | Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
CN101062925A (en) * | 2006-04-28 | 2007-10-31 | 中国医学科学院药物研究所 | Paclitaxel derivatives, preparation method and medicinal composition and usage thereof |
CN102532065A (en) * | 2011-12-13 | 2012-07-04 | 重庆泰濠制药有限公司 | Synthesis method of cabazitaxel |
CN103242267A (en) * | 2012-02-03 | 2013-08-14 | 福建南方制药股份有限公司 | Preparation method for cabazitaxel and intermediate thereof, and cabazitaxel intermediate |
WO2014072996A2 (en) * | 2012-11-09 | 2014-05-15 | Intas Pharmaceuticals Limited | Process for the preparation of cabazitaxel and its intermediates |
-
2014
- 2014-06-19 CN CN201410276150.5A patent/CN104086514A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151740A (en) * | 1994-06-28 | 1997-06-11 | 法玛西雅厄普约翰美国公司 | 7-ether-taxol analogs, antineoplastic use and pharmaceutical compsns. containing them |
EP0694539A1 (en) * | 1994-07-28 | 1996-01-31 | Bristol-Myers Squibb Company | 7-o-Ethers of taxane derivatives |
CN1179775A (en) * | 1995-03-27 | 1998-04-22 | 罗纳-布朗克罗莱尔股份有限公司 | Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
CN1179776A (en) * | 1995-03-27 | 1998-04-22 | 罗纳-布朗克罗莱尔股份有限公司 | Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
CN101062925A (en) * | 2006-04-28 | 2007-10-31 | 中国医学科学院药物研究所 | Paclitaxel derivatives, preparation method and medicinal composition and usage thereof |
CN102532065A (en) * | 2011-12-13 | 2012-07-04 | 重庆泰濠制药有限公司 | Synthesis method of cabazitaxel |
CN103242267A (en) * | 2012-02-03 | 2013-08-14 | 福建南方制药股份有限公司 | Preparation method for cabazitaxel and intermediate thereof, and cabazitaxel intermediate |
WO2014072996A2 (en) * | 2012-11-09 | 2014-05-15 | Intas Pharmaceuticals Limited | Process for the preparation of cabazitaxel and its intermediates |
Non-Patent Citations (4)
Title |
---|
CAIHONG LI ET AL.: "Biological evaluation of new antitumor taxoids: Alteration of substitution at the C-7 and C-10 of docetaxel", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 * |
CAIHONG LI ET AL.: "Biological evaluation of new antitumor taxoids: Alteration of substitution at the C-7 and C-10 of docetaxel", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》, vol. 24, 27 December 2013 (2013-12-27), XP028819895, DOI: doi:10.1016/j.bmcl.2013.12.083 * |
DANIEL GUÉNARD ET AL.: "Effect of the Hydrophobicity of Taxoids on their Interaction with Tubulin", 《BIOORGANIC & MEDICINAL CHEMISTRY》 * |
XIN CHE ET AL.: "Isolation and Characterizaiton of process-related impurities and degradation products in larotaxel", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107141272A (en) * | 2017-06-30 | 2017-09-08 | 重庆市碚圣医药科技股份有限公司 | A kind of semi-synthetic docetaxel method and its intermediate |
WO2020177748A1 (en) * | 2019-03-05 | 2020-09-10 | 中国医学科学院药物研究所 | Quaternized modified taxane derivative, and pharmaceutical composition and use thereof |
CN111662250A (en) * | 2019-03-05 | 2020-09-15 | 中国医学科学院药物研究所 | Quaternized modified taxane derivative, pharmaceutical composition, synthetic route and application thereof |
CN111662250B (en) * | 2019-03-05 | 2023-12-15 | 中国医学科学院药物研究所 | Quaternized modified taxane derivatives, pharmaceutical compositions thereof, synthetic routes and uses thereof |
CN113698368A (en) * | 2021-08-27 | 2021-11-26 | 无锡紫杉药业有限公司 | Preparation method of cabazitaxel |
CN113698369A (en) * | 2021-08-31 | 2021-11-26 | 无锡紫杉药业有限公司 | Method for removing specific single impurity in cabazitaxel |
CN115232092A (en) * | 2022-05-19 | 2022-10-25 | 无锡紫杉药业有限公司 | Preparation method of 10-acetyl docetaxel |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cao et al. | Synthesis and structure–activity relationships of harmine derivatives as potential antitumor agents | |
Wang et al. | The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: Synthesis and biological evaluation of ent-6, 7-seco-oridonin derivatives as novel potential anticancer agents | |
CN104086514A (en) | Paclitaxel derivatives and preparation method thereof | |
CN113698401B (en) | Beta-elemene macrocyclic derivatives, preparation method and application thereof | |
CN102584780B (en) | Glaucocalyxin derivative as well as preparing method and application thereof | |
CN109134586A (en) | Tripterine derivate and its application | |
Hu et al. | Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation | |
CN108383892B (en) | Diosgenin quaternary ammonium salt derivative and preparation method and application thereof | |
Kletskov et al. | Synthesis and biological activity of novel comenic acid derivatives containing isoxazole and isothiazole moieties | |
CN114195814A (en) | Hydroxy naphthalenone-phenylboronic acid compound, preparation method and application | |
Ke et al. | Synthesis and in vitro biological evaluation of novel derivatives of Flexicaulin A condensation with amino acid trifluoroacetate | |
EP2233467B1 (en) | Alpha-amino-n-substituted amides, pharmaceutical composition containing them and uses thereof | |
EP2862869B1 (en) | Acylated derivatives of polyphyllin i, preparation method therefor and application thereof | |
CN109111419B (en) | 7, 8-coumarin derivative containing substituent, preparation method and application thereof | |
CN105367575B (en) | A kind of folacin compound, its preparation method and medical usage | |
CN113004301B (en) | Artesunate-based-diphenylurea derivative ARS-DPU as well as preparation method and application thereof | |
CN115073406B (en) | Eucalyptus type sesquiterpene lactone TBA derivative and application thereof | |
CN111777577A (en) | Taxol derivative and application thereof in preparation of medicine for preventing and treating human malignant tumor | |
CN106632297A (en) | Docetaxel side chain 2'-derived novel taxanes antitumor compound as well as synthesis method and application thereof | |
WO2017036128A1 (en) | Alkaloid compound, preparation method thereof and use thereof as antiviral agent against herpes simplex virus type 1 | |
Mustafa et al. | Synthesis, antioxidant and antitumor activities of new coumarins grafted to 5-fluorouracil | |
CN102241648A (en) | Multimedicine-resistance medicine-resistance taxane derivatives and preparation method and use thereof | |
CN110804084B (en) | Quaternary phosphonium salt diosgenin derivative and synthesis method and application thereof | |
Amrine | Studies on Epipolythiodioxopiperazine Alkaloids | |
CN113387808B (en) | Tagalsin C diterpene derivative and preparation and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141008 |